Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer (Q38471361)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 August 2011

Language	Label	Description	Also known as
English	Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer	scientific article published on 16 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer (English)

1 reference

Europe PubMed Central

3 September 2017

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

object named as

Jung Min Chang

4

0 references

object named as

Keon Wook Kang

7

0 references

9

object named as

Dong-Young Noh

1 reference

Europe PubMed Central

3 September 2017

5

object named as

Seock-Ah Im

1 reference

Europe PubMed Central

3 September 2017

8

object named as

Wonshik Han

1 reference

Europe PubMed Central

3 September 2017

2

object named as

Woo Kyung Moon

1 reference

Europe PubMed Central

3 September 2017

3

object named as

Nariya Cho

1 reference

Europe PubMed Central

3 September 2017

author name string

Sang Hee Park

1

1 reference

Europe PubMed Central

3 September 2017

In Ae Park

6

1 reference

Europe PubMed Central

3 September 2017

language of work or name

0 references

publication date

16 August 2011

1 reference

Europe PubMed Central

3 September 2017

European Radiology

1 reference

Europe PubMed Central

3 September 2017

22

1 reference

Europe PubMed Central

3 September 2017

18-25

1 reference

Europe PubMed Central

3 September 2017

1

1 reference

Europe PubMed Central

3 September 2017

https://scigraph.springernature.com/pub.10.1007/s00330-011-2236-x

0 references

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

FDG PET, PET/CT, and breast cancer imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Response to therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Imaging gliomas with positron emission tomography and single-photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2236-X

21 January 2018

Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between PET-FDG and MRI apparent diffusion coefficients in brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally Advanced and Inflammatory Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21845462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-011-2236-X

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38471361&oldid=1761302456"